Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurofascin (NFASC) is a cell adhesion molecule belonging to the L1 subgroup of the immunoglobulin superfamily, produced in multiple isoforms by alternative splicing, and predominantly expressed in the central and peripheral nervous systems. It is localized at the axon initial segment (AIS) and nodes of Ranvier, where it interacts with voltage-gated sodium channels, ankyrin-G, and βIV-spectrin, forming specialized neuronal domains critical for saltatory conduction and neural signaling. Neurofascin is essential for synapse formation, axonal organization, and myelin-axon integrity, acting as a link between extracellular matrices and the cytoskeleton. Loss or mutation of neurofascin results in severe neurodevelopmental disorders, profound motor deficits, and ataxia; it is also a target of autoantibodies in certain autoimmune neuropathies, increasing disease severity by impairing axonal integrity and repair.
Not applicable; monoclonal autoantibodies against neurofascin can be pathogenic by disrupting axonal conduction and myelination
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurofascin (NFASC).